Table IV.
Methylation status of PCDH-γ-A12, SLC19A1, CREB and CYLD genes in lymph metastasis and non-lymph metastasis colorectal cancer tissues.
| Gene | Subgroup | Total | M | U | M% | χ2 | P-value |
|---|---|---|---|---|---|---|---|
| PCDH-γ-A12 | Cases | 21 | 21 | 0 | 100.00 | 6.171 | 0.013 |
| Controls | 21 | 14 | 7 | 66.67 | |||
| SLC19A1 | Cases | 21 | 20 | 1 | 95.24 | 5.091 | 0.024 |
| Controls | 21 | 13 | 8 | 61.90 | |||
| CREB | Cases | 21 | 7 | 14 | 33.33 | 1.109 | 0.292 |
| Controls | 21 | 4 | 17 | 19.05 | |||
| CYLD | Cases | 21 | 4 | 17 | 19.05 | 0.194 | 0.659 |
| Controls | 21 | 2 | 19 | 9.52 |
PCDH-γ-A12, protocadherin γ subfamily A12; SLC19A1, solute carrier family 19 A 1; CREB, cAMP responsive element binding protein; CYLD, cylindromatosis; M, methylated; U, unmethylated.